Aarti Pharmalabs Ltd

BSE: 543748

159

total announcements

543748.BO · 15 min delayed

Announcements Discussion

BSECompany UpdateMgmt Change13h ago

Aarti Pharmalabs Ltd

Aarti Pharmalabs Ltd has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Aarti Pharmalabs Ltd has informed BSE about the cessation of its Chief Financial Officer.

BSECompany UpdateMgmt Change14h ago

Aarti Pharmalabs Ltd

Please find enclosed

Aarti Pharmalabs Ltd has announced the resignation of its CFO, Piyush Lakhani, and the appointment of Vibha Thakkar as the new CFO, effective October 31, 2026. The company has also released its unaudited financial results for the quarter and half year ended September 30, 2026.

Read more →📎 1 attachment

BSECompany UpdateMgmt Change14h ago

Aarti Pharmalabs Ltd

Please find enclosed

Aarti Pharmalabs Ltd has announced the resignation of its Chief Financial Officer (CFO) Piyush Lakhani, effective October 30, 2026, and the appointment of Vibha Thakkar as the new CFO, effective October 31, 2026. The company has also released its unaudited financial results for the quarter and half year ended September 30, 2026.

Read more →📎 1 attachment

BSEResultResults14h ago

Aarti Pharmalabs Ltd

Please find enclosed

Aarti Pharmalabs Ltd has announced unaudited financial results for the quarter and half year ended September 30, 2026, and the resignation of CFO Piyush Lakhani and appointment of new CFO Vibha Thakkar.

Read more →📎 1 attachment

BSEBoard MeetingResults14h ago

Aarti Pharmalabs Ltd

Please find enclosed

Aarti Pharmalabs Ltd has announced its unaudited financial results for the quarter and half year ended September 30, 2026, and has also disclosed the resignation of its CFO, Piyush Lakhani, and the appointment of Vibha Thakkar as the new CFO.

Read more →📎 1 attachment

BSECompany Update15h ago

Aarti Pharmalabs Ltd

Please find enclosed

Aarti Pharmalabs Ltd has revamped its website to improve design, navigation, and accessibility, as per SEBI listing regulations.

Read more →📎 1 attachment

BSECompany UpdateMgmt Change15h ago

Aarti Pharmalabs Ltd

Please find enclosed

Aarti Pharmalabs Ltd has informed about the grant of 850 stock options to eligible employees under the APL Performance Stock Option Plan 2023 at an exercise price of Rs. 5 per option.

Read more →📎 1 attachment

BSECompany UpdateResults6d ago

Aarti Pharmalabs Ltd

This is to inform you that the Earnings Conference Call for investors and analysts has been scheduled for Thursday, October 28, 2026, at 3:30 p.m. (IST) to discuss the Company''s Q2-FY27 Financial Results

Aarti Pharmalabs Ltd has scheduled an earnings conference call on October 29, 2026, to discuss its Q2-FY27 financial results.

Read more →📎 1 attachment

BSEBoard MeetingResults9 Oct 2026

Aarti Pharmalabs Ltd

Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2026 ,inter alia, to consider and approve Unaudited Standalone And Consolidated Financial Results For The Second Quarter And Half Year Ended September 30, 2026

Aarti Pharmalabs Ltd has scheduled a board meeting on October 28, 2026, to consider and approve unaudited standalone and consolidated financial results for the second quarter and half year ended September 30, 2026.

Read more →📎 1 attachment

BSECompany Update9 Oct 2026

Aarti Pharmalabs Ltd

Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, for the quarter ended September 30, 2026.

Aarti Pharmalabs Ltd has received a Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, confirming the dematerialisation of securities for the quarter ended September 30, 2026.

Read more →📎 1 attachment

BSECompany UpdateRegulatory30 Sept 2026

Aarti Pharmalabs Ltd

Please find enclosed

Aarti Pharmalabs Ltd has filed a writ petition challenging the order of the Superintendent of Stamps, Gujarat, levying stamp duty and penalties totaling Rs. 59,50,00,000/- in respect of the Scheme of Arrangement (Demerger) sanctioned by the Hon'ble NCLT, Ahmedabad Bench.

Read more →📎 1 attachment

BSECompany UpdateMgmt Change30 Sept 2026

Aarti Pharmalabs Ltd

Please find enclosed

Aarti Pharmalabs Ltd has informed the exchange about the reconstitution of its Nomination and Remuneration Committee, effective from October 1, 2026, with Smt. Jeenal Savla as the Chairperson and three other members.

Read more →📎 1 attachment

BSEInsider Trading / SASTinsider_trading28 Sept 2026

Aarti Pharmalabs Ltd

Closure of Trading Window

Aarti Pharmalabs Ltd has announced the closure of its trading window from October 1, 2026, until 48 hours after the declaration of its financial results for the quarter ending September 30, 2026.

Read more →📎 1 attachment